ConductScience.org, home

Paper19259318

Prognostic factors for squamous cell cancer of the anal canal.

Das P and 3 others. Gastrointest Cancer Res, 2008. Cited by 35 papers, by iCite.

Cite this record

ConductScience Library. Prognostic factors for squamous cell cancer of the anal canal. Papers, record 19259318. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19259318

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prognostic factors for squamous cell cancer of the anal canal.
PubMed
Journal
Gastrointest Cancer Res
PubMed
Year
2008
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
35
iCite
Relative citation ratio, by iCite
0.76
iCite
Revised in PubMed
2023-11-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Das PPrajnan
2Crane CHChristopher H
3Eng CCathy
4Ajani JAJaffer A

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18874455
Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research.
Lancet1996https://conductscience.org/library/papers/8874455PubMed
211598480HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.Dis Colon Rectum2001https://conductscience.org/library/papers/11598480PubMed
38823332
Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.
J Clin Oncol1996https://conductscience.org/library/papers/8823332PubMed
416916475Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy.Radiat Oncol2006https://conductscience.org/library/papers/16916475PubMed
53698757Prognosis of cloacogenic and squamous cancers of the anal canal.Dis Colon Rectum1986https://conductscience.org/library/papers/3698757PubMed
616245310Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response.Cancer2005https://conductscience.org/library/papers/16245310PubMed
72376397Prognostic factors in anal squamous carcinoma: a multivariate analysis of clinical, pathological and flow cytometric parameters in 235 cases.Histopathology1990https://conductscience.org/library/papers/2376397PubMed
816938816Chemoradiotherapy in patients with anal cancer: impact of length of unplanned treatment interruption on outcome.Acta Oncol2006https://conductscience.org/library/papers/16938816PubMed
915719440Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation.Cancer2005https://conductscience.org/library/papers/15719440PubMed
1016028002Positron Emission Tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal.Mol Imaging Biol2005https://conductscience.org/library/papers/16028002PubMed
119559628Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?Dis Colon Rectum1998https://conductscience.org/library/papers/9559628PubMed
129336145Time-dose considerations in the treatment of anal cancer.Int J Radiat Oncol Biol Phys1997https://conductscience.org/library/papers/9336145PubMed
1316396154Management of anal cancer in the HIV-positive population.Oncology (Williston Park)2005https://conductscience.org/library/papers/16396154PubMed
142599902Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases.Int J Radiat Oncol Biol Phys1989https://conductscience.org/library/papers/2599902PubMed
152724350Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314.J Natl Cancer Inst1989https://conductscience.org/library/papers/2724350PubMed
1616626889FDG-PET/CT in the evaluation of anal carcinoma.Int J Radiat Oncol Biol Phys2006https://conductscience.org/library/papers/16626889PubMed
1710435807Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.Radiother Oncol1999https://conductscience.org/library/papers/10435807PubMed
189069302Conservative treatment by irradiation of epidermoid cancers of the anal canal: prognostic factors of tumoral control and complications.Int J Radiat Oncol Biol Phys1997https://conductscience.org/library/papers/9069302PubMed
1911319280Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.Am J Clin Oncol2001https://conductscience.org/library/papers/11319280PubMed
2015752894Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.Int J Radiat Oncol Biol Phys2005https://conductscience.org/library/papers/15752894PubMed

See all 54 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 35 citations.

PMIDTitleJournalYearIn PapersSource
39330009Factors Influencing Outcomes and Survival in Anal Cancer.Curr Oncol2024https://conductscience.org/library/papers/39330009PubMed
38464575Ectopic production of beta-hCG in anal cancer: A case report.Clin Case Rep2024https://conductscience.org/library/papers/38464575PubMed
36402828Influence of radiation treatment technique (IMRT vs. 3D-RT) on acute toxicity and prognostic factors for survival for anal cancer.Sci Rep2022https://conductscience.org/library/papers/36402828PubMed
35751111Leukocyte subtyping predicts for treatment failure and poor survival in anal squamous cell carcinoma.BMC Cancer2022https://conductscience.org/library/papers/35751111PubMed
35659632Prognostic factors for patients with anal cancer treated with conformal radiotherapy-a systematic review.BMC Cancer2022https://conductscience.org/library/papers/35659632PubMed
32803517Racial/Ethnic Disparities in Survival Among Women Diagnosed with Invasive Cancer of the Anal Canal: an Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.J Gastrointest Cancer2021https://conductscience.org/library/papers/32803517PubMed
32781500Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies.J Clin Med2020https://conductscience.org/library/papers/32781500PubMed
31559389Anal squamous cell carcinoma with metastasis to duodenum causing duodenal stricture and gastric outlet obstruction.AME Case Rep2019https://conductscience.org/library/papers/31559389PubMed
30662475Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.J Contemp Brachytherapy2018https://conductscience.org/library/papers/30662475PubMed
30627062Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis.Contrast Media Mol Imaging2018https://conductscience.org/library/papers/30627062PubMed
29623585The effect of dose escalation for large squamous cell carcinomas of the anal canal.Clin Transl Oncol2018https://conductscience.org/library/papers/29623585PubMed
27923035Biomarkers in anal cancer: from biological understanding to stratified treatment.Br J Cancer2017https://conductscience.org/library/papers/27923035PubMed
27044498Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer.Radiat Oncol2016https://conductscience.org/library/papers/27044498PubMed
26186412Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations.CA Cancer J Clin2015https://conductscience.org/library/papers/26186412PubMed
24014082HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.J Gastrointest Cancer2013https://conductscience.org/library/papers/24014082PubMed
23184242[Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience].Radiol Med2013https://conductscience.org/library/papers/23184242PubMed
22697293High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy.Radiat Oncol2012https://conductscience.org/library/papers/22697293PubMed
21063399Prognostic biomarkers in squamous cell carcinoma of the anus: a systematic review.Br J Cancer2010https://conductscience.org/library/papers/21063399PubMed
19231109Intensity-modulated radiation therapy for the treatment of squamous cell anal cancer with para-aortic nodal involvement.Int J Radiat Oncol Biol Phys2009https://conductscience.org/library/papers/19231109PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CCNA2890PubTator's text mininghttps://conductscience.org/library/genes/890NCBI Gene
H3P16644914PubTator's text mininghttps://conductscience.org/library/genes/644914NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19259318

GET https://conductscience.org/api/papers/v1/19259318/references?page=2